Select Page

Chas McKhann

Position: Chief Executive Officer

Chas McKhann is the Chief Executive Officer of Silk Road Medical. Prior to Silk Road Medical, Chas was President and CEO of Apollo Endosurgery, where he created and led a transformational growth strategy for this publicly traded manufacturer of minimally invasive technologies for gastrointestinal and bariatric conditions. Apollo was acquired by Boston Scientific in April 2023. Previously, Chas served as Chief Commercial Officer at Torax Medical before its acquisition by Johnson & Johnson, and CCO at Intersect ENT, leading the commercial organizations, including sales, marketing, health economics & reimbursement, and strategic planning. Earlier in his career, Chas was CEO at Apnex Medical, Worldwide Vice President of Marketing for cardiac rhythm management at Boston Scientific, and Director of Marketing at Cordis, where he launched CYPHER®, a sirolimus-eluting coronary stent that was the first cardiac drug-eluting stent. Chas holds a BA in Political Science and an MBA from Stanford University.